0001843252-22-000001.txt : 20221020 0001843252-22-000001.hdr.sgml : 20221020 20221019193940 ACCESSION NUMBER: 0001843252-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221020 DATE AS OF CHANGE: 20221019 EFFECTIVENESS DATE: 20221020 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vita Therapeutics, Inc. CENTRAL INDEX KEY: 0001843252 IRS NUMBER: 832995717 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-462316 FILM NUMBER: 221319514 BUSINESS ADDRESS: STREET 1: 1812 ASHLAND AVENUE STREET 2: UNIT 110 CITY: BALTIMORE STATE: MD ZIP: 21205 BUSINESS PHONE: 609-339-5126 MAIL ADDRESS: STREET 1: 1812 ASHLAND AVENUE STREET 2: UNIT 110 CITY: BALTIMORE STATE: MD ZIP: 21205 D 1 primary_doc.xml X0708 D LIVE 0001843252 Vita Therapeutics, Inc. 801 W. Baltimore Street Suite 301 BALTIMORE MD MARYLAND 21201 609-339-5126 DELAWARE None None Corporation true 2018 Douglas Falk 801 W. Baltimore Street Suite 301 Baltimore MD MARYLAND 21201 Executive Officer Director Vlad Coric 801 W. Baltimore Street Suite 301 Baltimore MD MARYLAND 21201 Director Eva Chin 801 W. Baltimore Street Suite 301 Baltimore MD MARYLAND 21201 Director David Churchill 801 W. Baltimore Street Suite 301 Baltimore MD MARYLAND 21201 Director Mark Nuttall 801 W. Baltimore Street Suite 301 Baltimore MD MARYLAND 21201 Director James Peyer 801 W. Baltimore Street Suite 301 Baltimore MD MARYLAND 21201 Director Biotechnology Not Applicable 06b false 2022-10-11 false true false 0 30892998 30892998 0 false 7 0 0 0 false Vita Therapeutics, Inc. /s/ Douglas Falk Douglas Falk Chief Executive Officer 2022-10-19